|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8200 AUD | -3.53% |
|
+1.86% | -24.42% |
| 08/04 | Orthocell Says Proposed US Pharmaceutical Tariffs Not Expected to Apply to Remplir; Shares Up 4% | MT |
| 08/04 | Orthocell says US Section 232 tariffs not expected to affect Remplir | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 16Cr | - | - | - | - | - |
| 19TCr | - | - | - | - | |
| 16TCr | |||||
| 14TCr | |||||
| 9.11TCr | |||||
| 4.87TCr |
- Stock Market
- Equities
- OCC Stock
- Charts Orthocell Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition